Literature DB >> 33901729

Caring for Families Impacted by Opioid Use: A Qualitative Analysis of Integrated Program Designs.

Davida M Schiff1, Shayla Partridge2, Nina H Gummadi3, Jessica R Gray4, Sara Stulac5, Eileen Costello5, Elisha M Wachman6, Hendrée E Jones7, Shelly F Greenfield8, Elsie M Taveras2, Judith A Bernstein9.   

Abstract

OBJECTIVE: We sought to 1) identify models of integrated care that offer medical care and social services for children and families impacted by opioid use disorder (OUD) in the postpartum year; and 2) describe how each program was developed, designed, and sustained, and explore facilitators and barriers to implementation of a dyadic, two-generation approach to care.
METHODS: In-depth semi-structured interviews (n = 23) were conducted with programs for women and children affected by OUD across North America. Using a phenomenologic approach, key program components and themes were identified. Following thematic saturation, these results were triangulated with experts in program implementation and with a subset of key informants to ensure data integrity.
RESULTS: Five distinct types of programs were identified that varied in the degree of medical and behavioral care for families. Three themes emerged unique to the provision of dyadic care: 1) families require supportive, frequent visits with a range of providers, but constraints around billable services limit care integration across the perinatal continuum; 2) individual program champions are critical, but degree and reach of interdisciplinary care is limited by siloed systems for medical and behavioral care; and 3) addressing dual, sometimes competing, responsibilities for both parental and infant health following recurrence of parental substance use presents unique challenges.
CONCLUSIONS: The key components of dyadic care models for families impacted by OUD included prioritizing care coordination, removing barriers to integrating medical and behavioral services, and ensuring the safety of children in homes with ongoing parental substance use while maintaining parental trust.
Copyright © 2021 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  family-based care; neonatal abstinence syndrome; opioid use disorder; opioid-exposed dyad; postpartum

Mesh:

Substances:

Year:  2021        PMID: 33901729      PMCID: PMC8542059          DOI: 10.1016/j.acap.2021.04.016

Source DB:  PubMed          Journal:  Acad Pediatr        ISSN: 1876-2859            Impact factor:   3.107


  28 in total

1.  Barriers to physical and mental condition integrated service delivery.

Authors:  Roger G Kathol; Mary Butler; Donna D McAlpine; Robert L Kane
Journal:  Psychosom Med       Date:  2010-05-24       Impact factor: 4.312

2.  Exposure to violence among substance-dependent pregnant women and their children.

Authors:  Martha L Velez; Ivan D Montoya; Lauren M Jansson; Vickie Walters; Dace Svikis; Hendree E Jones; Howard Chilcoat; Jacquelyn Campbell
Journal:  J Subst Abuse Treat       Date:  2006-01

Review 3.  Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder.

Authors:  Christine Wilder; Daniel Lewis; Theresa Winhusen
Journal:  Drug Alcohol Depend       Date:  2015-02-19       Impact factor: 4.492

4.  Incidence and Costs of Neonatal Abstinence Syndrome Among Infants With Medicaid: 2004-2014.

Authors:  Tyler N A Winkelman; Nicole Villapiano; Katy B Kozhimannil; Matthew M Davis; Stephen W Patrick
Journal:  Pediatrics       Date:  2018-04       Impact factor: 7.124

Review 5.  Maternal substance use and child protection: a rapid evidence assessment of factors associated with loss of child care.

Authors:  Martha Canfield; Polly Radcliffe; Sally Marlow; Marggie Boreham; Gail Gilchrist
Journal:  Child Abuse Negl       Date:  2017-05-25

Review 6.  Coordinating primary health care: an analysis of the outcomes of a systematic review.

Authors:  Gawaine Powell Davies; Anna M Williams; Karen Larsen; David Perkins; Martin Roland; Mark F Harris
Journal:  Med J Aust       Date:  2008-04-21       Impact factor: 7.738

7.  Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.

Authors:  Elisha M Wachman; A Hutcheson Warden; Zoe Thomas; Jo Ann Thomas-Lewis; Hira Shrestha; F N U Nikita; Daniel Shaw; Kelley Saia; Davida M Schiff
Journal:  Drug Alcohol Depend       Date:  2018-09-01       Impact factor: 4.492

8.  How personal and standardized coordination impact implementation of integrated care.

Authors:  Justin K Benzer; Irene E Cramer; James F Burgess; David C Mohr; Jennifer L Sullivan; Martin P Charns
Journal:  BMC Health Serv Res       Date:  2015-10-02       Impact factor: 2.655

9.  Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014.

Authors:  Sarah C Haight; Jean Y Ko; Van T Tong; Michele K Bohm; William M Callaghan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-10       Impact factor: 17.586

10.  State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome.

Authors:  Charlan D Kroelinger; Marion E Rice; Shanna Cox; Hadley R Hickner; Mary Kate Weber; Lisa Romero; Jean Y Ko; Donna Addison; Trish Mueller; Carrie Shapiro-Mendoza; S Nicole Fehrenbach; Margaret A Honein; Wanda D Barfield
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-09-13       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.